Safety and Efficacy of Tamoxifen in Boys With Duchenne Muscular Dystrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet Neurol 2023 Oct 01;22(10)890-899, BC Henzi, S Schmidt, S Nagy, D Rubino-Nacht, S Schaedelin, N Putananickal, G Stimpson, , H Amthor, AM Childs, N Deconinck, I de Groot, I Horrocks, S Houwen-van Opstal, V Laugel, M Lopez Lobato, M Madruga Garrido, A Nascimento Osorio, U Schara-Schmidt, S Spinty, A von Moers, F Lawrence, P Hafner, OM Dorchies, D FischerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.